Global Polymerase Chain Reaction (PCR) Market Expected to Grow Till 2021

Polymerase chain reaction (PCR) is a routinely used system in life science laboratories to amplify small amount of DNA. PCR applications have increased radically in the recent past due to surge in genetic research. The technology has been applied in varied areas including agriculture, forensic, disease diagnosis and bio-pharmaceutical research. Recently the technology has been integrated with therapeutic application in companion diagnostics. PCR technology witnessed swift acceptance among researchers across the globe due to wide scope of application, low cost, and ease of operation. In spite of introduction of various advanced technologies, PCR has still remained a mainstay in basic DNA research. The global polymerase chain reaction market is segmented into two broad categories on basis of technology into: digital PCR and quantitative PCR; and by components into: devices, reagents and consumables, and software.

Polymerase chain reaction market is largely driven by regulatory approval of PCR based diagnostic tests, allowing rapid growth in the clinical application segment. In 2016, the U.S. FDA issued Emergency Use Authorization (EUA) for a number of PCR based tests for Zika virus diagnosis. Some of the tests authorized by the regulatory agency include LightMix Zika rRT-PCR test by Roche Diagnostics, and Zika Virus RNA Qualitative RT-PCR test by Quest Diagnostics among three others. In 2015, FDA also cleared cobas Influenza A/B test, an rt-PCR based test by Roche for diagnosis and differentiation of Influenza-A and -B variants. Development of drug resistance is also become a growing crisis for which accurate diagnosis in early stage has become paramount.? Companion diagnostics allows physicians to make informed decisions prior to prescribing cancer treatment. This has helped in increasing success rate to a large extent. With this, PCR has found an important position in cancer diagnosis and treatment which is related to millions of mortalities globally. Considering these success parameters, the technology is gradually being applied in various medical fields. The global PCR market is also expected to boost with increasing incidences of disease and need for rapid disease diagnosis.

Free Sample Report@ http://www.sa-brc.com/Global-Polymerase-Chain-Reaction-PCR-Market-Assessment--Forecast-2017-2021/up80

Large percentage of the global polymerase chain reaction market has been concentrated in the North America and Europe. Latin America and Asia Pacific have higher percentage of share in research, as compared to medical applications. Evolving healthcare sector in developing countries in these regions would assist PCR applications in medical field, thus driving the overall market.

The polymerase chain reaction market is largely fragmented with more than 15 major players operating globally. Key players in the polymerase chain reaction market include Agilent Technologies, bioM?rieux, Bio-Rad Laboratories Ltd, Roche Diagnostics, Qiagen N.V., Thermo Fisher Scientific and others.

Click For TOC@ http://www.sa-brc.com/Global-Polymerase-Chain-Reaction-PCR-Market-Assessment--Forecast-2017-2021/upcomingdetail80

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.